Fate Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Fate Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $17M | 10M | 1.65 |
2024-09-30 | $36M | 10M | 3.50 |
2024-06-30 | $35M | 11M | 3.28 |
2024-03-31 | $73M | 9.9M | 7.34 |
2023-12-31 | $35M | 9.3M | 3.74 |
2023-09-30 | $23M | 11M | 2.12 |
2023-06-30 | $56M | 12M | 4.76 |
2023-03-31 | $63M | 11M | 5.70 |
2022-12-31 | $80M | 8.0M | 10.09 |
2022-06-30 | $192M | 7.8M | 24.78 |
2022-03-31 | $298M | 7.7M | 38.77 |
2021-09-30 | $452M | 7.6M | 59.27 |
2021-06-30 | $657M | 7.6M | 86.79 |
2021-03-31 | $616M | 7.5M | 82.45 |
2020-12-31 | $616M | 6.8M | 90.93 |
2020-09-30 | $251M | 6.3M | 39.97 |
2020-06-30 | $175M | 5.1M | 34.31 |
2020-03-31 | $72M | 3.3M | 22.21 |
2019-12-31 | $61M | 3.1M | 19.57 |
2019-09-30 | $47M | 3.1M | 15.53 |
2019-03-31 | $48M | 2.7M | 17.57 |
2018-12-31 | $33M | 2.5M | 12.89 |
2018-09-30 | $40M | 2.4M | 16.29 |
2018-06-30 | $25M | 2.2M | 11.34 |
2018-03-31 | $18M | 1.8M | 9.75 |
2017-12-31 | $8.9M | 1.5M | 6.12 |
2017-09-30 | $5.1M | 1.3M | 3.95 |
2017-06-30 | $4.1M | 1.3M | 3.24 |
2017-03-31 | $5.2M | 1.2M | 4.53 |
2016-12-31 | $1.6M | 632k | 2.53 |
2016-09-30 | $2.1M | 688k | 3.07 |
2016-06-30 | $1.1M | 658k | 1.73 |
2015-12-31 | $1.4M | 415k | 3.33 |
2015-09-30 | $2.0M | 369k | 5.33 |
2015-06-30 | $2.2M | 337k | 6.47 |
2015-03-31 | $883k | 181k | 4.89 |
2014-12-31 | $865k | 172k | 5.03 |
2014-09-30 | $884k | 172k | 5.14 |
2014-06-30 | $938k | 149k | 6.31 |
2014-03-31 | $1.4M | 149k | 9.74 |
2013-12-31 | $116k | 19k | 6.26 |